ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 222

Acupuncture for Chronic Musculoskeletal Pain: A Review of Randomized Controlled Trials

Yujuan Zhang1 and Chenchen Wang 2, 1Floating Hospital at Tufts Medical Center, Boston, 2Tufts Medical Center, Boston

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: acupuncture, Chronic pain, clinical trials, Musculoskeletal and randomized trials

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Fibromyalgia & Other Clinical Pain Syndromes Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Acupuncture has been widely used for pain relief in adults. Evidence on effects of acupuncture for pediatric chronic musculoskeletal pain is scarce. We have reviewed existing randomized controlled trials, expecting to summarize the high-quality evidence of acupuncture on chronic musculoskeletal pain before advocating it in the pediatric population.

Methods: Methods: We performed a comprehensive search in MEDLINE as well as reference lists until June 2019. Selection criteria included: chronic musculoskeletal pain, randomized controlled trials, sample size ≥20.

Results: Results: We identified 16 randomized controlled trials with a total of 4039 subjects met the eligibility criteria. All the subjects were age 18 or older, with most of them middle aged. Number of trials included chronic pain in temporomandibular joint (1), neck (1), back or spine (7), knee (5), fibromyalgia (1) and rotator cuff tendinitis (1). Seven trials used traditional Chinese acupuncture, two used auricular acupressure, two used verum or bee venom acupuncture, one used electro-acupuncture, two used laser with acupuncture, and one used thread-embedding acupuncture. Ten of the 16 trials (62.5%) were either double or triple blinded. Mean treatment duration was 6.6 weeks (range from 10 days to 12 weeks). Table 1 summarizes the trials evaluating the effect of acupuncture on pain and the authors’ conclusions whether the acupuncture therapies were favorable. Of the 16 trials, 12 (75%) reported that the acupuncture therapy was effective compared to a variety of control groups; nine of those trials reported better pain reduction of acpunture s than sham/placebo groups. Among those 10 trials with double or triple blinded design, 7 out of 10 trials (70%) suggested acupuncture favorable. However, 4(25%) suggested that acupuncture was not more effective than the controlled/sham groups. One trial did show a pain reduction in acupuncture groups at 12 weeks but effects did not sustain at 1-year follow up.

Conclusion: Conclusion: Our review showed a mixed result in the effect of acupuncture in pain relief for chronic musculoskeletal pain. The majority of the trials suggested that acupuncture maybe effective beyond the placebo effect. To date, there are no high-quality trials in pediatric population. Rigorous and well-controlled randomized trials in pediatric population are warranted.


References


Table1


Disclosure: Y. Zhang, None; C. Wang, None.

To cite this abstract in AMA style:

Zhang Y, Wang C. Acupuncture for Chronic Musculoskeletal Pain: A Review of Randomized Controlled Trials [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/acupuncture-for-chronic-musculoskeletal-pain-a-review-of-randomized-controlled-trials/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/acupuncture-for-chronic-musculoskeletal-pain-a-review-of-randomized-controlled-trials/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology